4//SEC Filing
RIEDEL NORBERT G 4
Accession 0001437749-25-000466
CIK 0001710340other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:22 PM ET
Size
13.2 KB
Accession
0001437749-25-000466
Insider Transaction Report
Form 4
RIEDEL NORBERT G
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-03$3.58/sh+27,400$98,092→ 87,145 total - Exercise/Conversion
Common Stock
2025-01-03$3.78/sh+50,000$189,000→ 137,145 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-01-03−27,400→ 0 totalExercise: $3.58From: 2021-03-12Exp: 2030-03-12→ Common Stock (27,400 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-01-03−50,000→ 0 totalExercise: $3.78From: 2023-02-07Exp: 2032-02-06→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2025-01-03$3.47/sh+25,000$86,750→ 162,145 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-01-03−25,000→ 0 totalExercise: $3.47From: 2024-02-20Exp: 2033-02-19→ Common Stock (25,000 underlying)
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001161662
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:22 PM ET
- Size
- 13.2 KB